StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report published on Wednesday. The firm issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a report on Wednesday, August 21st.
View Our Latest Analysis on Arcadia Biosciences
Arcadia Biosciences Trading Up 2.6 %
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.27 by ($0.49). The firm had revenue of $1.31 million during the quarter, compared to analyst estimates of $0.95 million. Arcadia Biosciences had a negative net margin of 127.29% and a negative return on equity of 57.51%. During the same period in the prior year, the firm earned ($2.64) earnings per share. On average, equities analysts predict that Arcadia Biosciences will post -1.7 earnings per share for the current year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Featured Articles
- Five stocks we like better than Arcadia Biosciences
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What Makes a Stock a Good Dividend Stock?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.